Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

21 та иш

Иш: The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)–Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings—A Prospective Cohort Study in Belarus and Uzbekistan

  1. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis

    Francesca Conradie, Andreas H. Diacon, Nosipho Ngubane +15

    Мақола20207 иқтибос
    ABI

  2. Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis

    Francesca Conradie, Tatevik R. Bagdasaryan, Borisov Se +25

    Мақола20226 иқтибос
    ABI

  3. A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

    Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis +15

    МақолаTuberculosis Research and EpidemiologyNew England Journal of Medicine20225 иқтибос
    ABI

  4. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support

    Paul A. Harris, Robert Taylor, Robert J. Thielke +3

    Мақола20085 иқтибос
    ABI

  5. Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives

    Emanuele Pontali, Mario Raviǵlione, Giovanni Battista Migliori

    Шарҳ мақола20195 иқтибос
    ABI

  6. The REDCap consortium: Building an international community of software platform partners

    Paul A. Harris, Robert J. Taylor, Brenda L. Minor +8

    Мақола20194 иқтибос
    ABI

  7. Safety and Effectiveness of an All-Oral, Bedaquiline-Based, Shorter Treatment Regimen for Rifampicin-Resistant Tuberculosis in High Human Immunodeficiency Virus (HIV) Burden Rural South Africa: A Retrospective Cohort Analysis

    Ilse Tack, Asnake Yohannes Dumicho, Liesbet Ohler +6

    Мақола20202 иқтибос
    ABI

  8. TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II–III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis

    Catherine Berry, Philipp du Cros, Katherine Fielding +7

    Мақола20222 иқтибос
    ABI

  9. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  10. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  11. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  12. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  13. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  14. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  15. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  16. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  17. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  18. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  19. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  20. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  21. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI